As biopharmaceuticals will soon make up 50% of new drug approvals there has been a significant rise in interest in the field of biosimilars.
Pablo Fernandez
Advertisement
Dr Pablo Fernandez is Senior Vice President, Medical Affairs, PharmaNet.
Articles by Pablo Fernandez
Advertisement
Latest Updated Articles
- The Changing Landscape For Biosimilars
Published: August 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
3
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
4
Drug Digest: Closing the Gap in Modern Process Control and Automation for Quality
5
